These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20456395)

  • 21. Pharmacogenetics of toxic epidermal necrolysis.
    Lee MT; Hung SI; Wei CY; Chen YT
    Expert Opin Pharmacother; 2010 Sep; 11(13):2153-62. PubMed ID: 20536296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum TARC levels are strongly correlated with blood eosinophil count in patients with drug eruptions.
    Komatsu-Fujii T; Kaneko S; Chinuki Y; Suyama Y; Ohta M; Niihara H; Morita E
    Allergol Int; 2017 Jan; 66(1):116-122. PubMed ID: 27497618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Borchers AT; Lee JL; Naguwa SM; Cheema GS; Gershwin ME
    Autoimmun Rev; 2008 Sep; 7(8):598-605. PubMed ID: 18603022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
    Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hung CC; Liu WC; Kuo MC; Lee CH; Hwang SJ; Chen HC
    Am J Nephrol; 2009; 29(6):633-8. PubMed ID: 19155617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection.
    Porteous DM; Berger TG
    Arch Dermatol; 1991 May; 127(5):740-1. PubMed ID: 1827245
    [No Abstract]   [Full Text] [Related]  

  • 27. T cell populations propagating in the peripheral blood of patients with drug eruptions.
    Nishio D; Izu K; Kabashima K; Tokura Y
    J Dermatol Sci; 2007 Oct; 48(1):25-33. PubMed ID: 17601705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
    Darlenski R; Kazandjieva J; Tsankov N
    Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entities.
    Miyagawa F; Hasegawa A; Imoto K; Ogawa K; Kobayashi N; Ito K; Fujita H; Aihara M; Watanabe H; Sueki H; Tohyama M; Asada H
    Eur J Dermatol; 2015; 25(1):87-9. PubMed ID: 25547780
    [No Abstract]   [Full Text] [Related]  

  • 30. Activity of Tumor Necrosis Factor-alpha (TNF-alpha) and its soluble type I receptor (p55TNF-R) in some drug-induced cutaneous reactions.
    Chodorowska G; Czelej D; Niewiedzioł M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):50-6. PubMed ID: 15323166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of liver injury in drug-induced systemic hypersensitivity reactions.
    Lee T; Lee YS; Yoon SY; Kim S; Bae YJ; Kwon HS; Cho YS; Moon HB; Kim TB
    J Am Acad Dermatol; 2013 Sep; 69(3):407-15. PubMed ID: 23632341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Yamane Y; Aihara M; Tatewaki S; Matsukura S; Kanbara T; Yamakawa Y; Ikezawa Z
    Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity.
    Hanafusa T; Azukizawa H; Matsumura S; Katayama I
    J Dermatol Sci; 2012 Mar; 65(3):213-9. PubMed ID: 22226608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome.
    Ishida T; Kano Y; Mizukawa Y; Shiohara T
    Allergy; 2014 Jun; 69(6):798-805. PubMed ID: 24749495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
    Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
    Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
    Ghislain PD; Roujeau JC
    Dermatol Online J; 2002 Jun; 8(1):5. PubMed ID: 12165215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
    Wanat KA; Anadkat MJ; Klekotka PA
    J Am Acad Dermatol; 2009 Apr; 60(4):589-94. PubMed ID: 19217690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.